Tournament: Jack Howe | Round: 2 | Opponent: Joey Antonelli | Judge: Joseph Barquin
Innovation low now – secondary patents gut the incentive and skyrocket price of Naloxone, HIV meds, insulin, and even basic allergy drugs – the only comprehensive study
AV 20 ("‘Evergreening’ Stunts Competition, Costs Consumers and Taxpayers." Arnold Ventures, Arnold Foundation, 24 Sept. 2020, www.arnoldventures.org/stories/evergreening-stunts-competition-costs-consumers-and-taxpayers/.)LK ~Accessed 8/23/2021~
In 2011, Elsa Dixler was diagnosed with multiple myeloma. That August, she
AND
billions of dollars while increasing the incentives for pharmaceutical companies to achieve breakthroughs."
They’re endemic to the industry and 80 of patents were not for new drugs – their stats ignore the quality of the innovation which is nonexistant
Robin 18 (Robin Feldman, May your drug price be evergreen, Journal of Law and the Biosciences, Volume 5, Issue 3, December 2018, Pages 590–647, https://doi.org/10.1093/jlb/lsy022 ~Robin Feldman, Hastings College of the Law, University of California~)LK ~Accessed 8/23/21~
IV.A. Overview The study results demonstrate definitively that the pharmaceutical industry has
AND
exclusivity, but also other significant changes such as adding a use code.)
Secondary patents are the root cause and less than 1/6 of revenues go to RandD – ignore their lies told by big pharma
Radhakrishnan 16 Priti Radhakrishnan 6-14-2016 "Pharma’s secret weapon to keep drug prices high" https://www.statnews.com/2016/06/14/secondary-patent-gilead-sovaldi-harvoni/ (Priti Radhakrishnan is cofounder and director of the Initiative for Medicines, Access and Knowledge (I-MAK), a US-based nonprofit group of scientists and lawyers working globally to get people lifesaving medicines. Before founding I-MAK, she worked as a health attorney in the US, Switzerland, and India.)Elmer LK ~RCT~
Skyrocketing drug prices are forcing states to take unprecedented measures to rein in health care
AND
are unmerited and that unjustly prolong companies’ market power and prevent legitimate competition.
Frontline AIDS ("How Patents Affect Access to Hiv Treatment." Frontline AIDS, 2 October 2019, frontlineaids.org/how-patents-affect-access-to-hiv-treatment/)LK ~Accessed 8/25/2021~ *pppy = per person per year
Since the world acknowledged the global AIDS epidemic in the 1980s much has changed.
AND
put into practice we risk undermining the commitments made to the HIV response.
We control uniqueness – innovation is low now and it solves disease, bioterror and antimicrobial resistance. The response to COVID is the exception, not the rule.
Marjanovic and Feijao 20 (Marjanovic, Sonja and Carolina Feijao, Pharmaceutical Innovation for Infectious Disease Management: From Troubleshooting to Sustainable Models of Engagement. Santa Monica, CA: RAND Corporation, 2020. https://www.rand.org/pubs/perspectives/PEA407-1.html)//LK ~Accessed 8/30/31~
We need to ensure scalable and sustainable approaches for pharmaceutical innovation in response to infectious
AND
different types of infectious disease threats and phases in framing incentives and regulation.
Srivatsa ’17 (Kadiyali; specialist in pediatric intensive and critical care medicine in the UK. Invented the bacterial identification tool ‘MAYA’; 1-12-2017; "Superbug Pandemics and How to Prevent Them", American Interest; https://www.the-american-interest.com/2017/01/12/superbug-pandemics-and-how-to-prevent-them/, Accessed: 8-31-2021; AU)
It is by now no secret that the human species is locked in a race
AND
most of the medical advances we have made over the past fifty years.
Hotez 16, Peter J. Blue marble health: an innovative plan to fight diseases of the poor amid wealth. JHU Press, 2016. (Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology)Elmer LK ~RCT 9/15/2021~
We also need to better understand how these NTDs are actually transmitted within US borders
AND
, Burkina Faso, and Niger, as well as Nigeria ~11~.
Nang and Martin 17, Roberto N., and Keith Martin. "Global health diplomacy: A new strategic defense pillar." Military medicine 182.1-2 (2017): 1456-1460. (MC, Global Health Division, Uniformed Services University of the Health Sciences)Elmer
INTRODUCTION: FORCE IF NECESSARY BUT NOT NECESSARILY FORCE The world appears unhinged. Instability
AND
the ability and authority to do so in the national and international interest.
Millett and Snyder-Beattie ‘17. Millett, Ph.D., Senior Research Fellow, Future of Humanity Institute, University of Oxford; and Snyder-Beattie, M.S., Director of Research, Future of Humanity Institute, University of Oxford. 08-01-2017. "Existential Risk and Cost-Effective Biosecurity," Health Security, 15(4), PubMed
In the decades to come, advanced bioweapons could threaten human existence. Although the
AND
still ought to invest more in preventing the most extreme possible biosecurity catastrophes.
Feldman 19 (Feldman, Robin. "Drug Patent Protection: It's Time for a 'One-and-Done' Approach." STAT, 11 Feb. 2019, www.statnews.com/2019/02/11/drug-patent-protection-one-done/. ~Robin Feldman is professor of law and director of the Institute for Innovation Law at UC Hastings College of the Law in San Francisco and author of "Drugs, Money, and Secret Handshakes" (Cambridge University Press, March 2019).~)LK ~Accessed 8/25/2021~
In a perfect world, the system for conveying medications from their makers to patients
AND
right now, the incentives for creating patent walls are just too great.
The standard is maximizing expecting well being.
—-A~ Aggregation – every policy benefits some and harms others, which also means side constraints freeze action.
The 1AC’s scholarship supplements resistance because it maps the supply lines and networks that create complex systems of power.
Bryant 12 – Levi Bryant Professor of Philosophy at Collin College. In addition to working as a professor, Bryant has also served as a Lacanian psychoanalyst. He received his Ph.D. from Loyola University in Chicago, Illinois, where he originally studied 'disclosedness' with the Heidegger scholar Thomas Sheehan. Bryant later changed his dissertation topic to the transcendental empiricism of Gilles Deleuze. "War Machines and Military Logistics: Some Cards on the Table" 9/15/2012. IB
We need answers to these questions to intervene effectively. We can call them questions
AND
, and communications networks, and so we can engage in effective terraformation.
Root cause explanations of international politics don’t exist – methodological pluralism is necessary to reclaim IR as emancipatory praxis and avoid endless political violence.
Bleiker ‘14 (6/17, Roland, Professor of International Relations at the University of Queensland, "International Theory Between Reification and Self-Reflective Critique," International Studies Review, Volume 16, Issue 2, pages 325–327)
This book is part of an increasing trend of scholarly works that have embraced poststructural
AND
and complexity theory—links that could have been explored in more detail.